Gastrointestinal Carcinoid Tumor Treatment
Gastrointestinal carcinoid tumors, also known as gastrointestinal neuroendocrine tumors (GI NETs), develop in the neuroendocrine cells that line the digestive tract. These specialized cells help regulate digestion by producing hormones that control the release of digestive juices (bile) and the movement of intestinal muscles.
GI NETs can form in the stomach, small intestine, appendix, colon or rectum. Because the cancer tends to grow slowly, it may not cause symptoms for many years, although some tumors release excess hormones into the bloodstream. As the tumor progresses, it may begin to cause abdominal pain. Other warning signs can include changes in bowel habits, such as persistent diarrhea or constipation, nausea or vomiting, rectal pain or bleeding and, less commonly, episodes of flushing related to excessive hormone production.
Overall, gastrointestinal carcinoid tumors are relatively uncommon, with an estimated 8,000 new cases diagnosed annually in the United States, most in adults over age 60.
Because GI NETs often behave differently from other gastrointestinal cancers, treatment must be highly individualized. In many cases, specialists across multiple disciplines work together to determine the most effective approach based on the location, grade, stage and extent of the tumor.
Surgery for gastrointestinal carcinoid tumors
Surgery is the most common and effective treatment for localized GI NETs. When the tumor is confined to the gastrointestinal tract and can be safely removed, surgery may offer the best chance for long-term cancer control or cure.
ACS Surgical Quality Partner for 30+ Years
Continuously Accredited by the American College of Surgeons Commission on Cancer since 1989 for our commitment to providing comprehensive, high-quality and multispecialty patient-centered care.
Depending on the characteristics of the tumor, surgical treatment may involve removing a small section of the digestive tract, nearby lymph nodes and, in some cases, a portion of the liver if metastasis is present. When possible, the surgeon will use advanced techniques to preserve healthy tissues and minimize recovery time.
Potential risks and side effects of gastrointestinal carcinoid tumor surgery
As with any surgical procedure, the risks of surgery for GI NETs include infection, bleeding, pain and anesthesia-related complications. The specific risks can vary depending on the type and extent of the surgery performed and the area of the digestive system involved. The healthcare team will review all potential risks when planning the procedure and take appropriate steps to help prevent complications.
Preparing for gastrointestinal carcinoid tumor surgery and recovery
Before surgery, the patient may undergo imaging tests, blood work and medical consultations to help ensure they are prepared for the procedure. While the recovery time can vary, many patients are able to resume light activities within a few weeks. The healthcare team will provide detailed guidance on wound care, nutrition and follow-up appointments.
Targeted therapy for gastrointestinal carcinoid tumors
Targeted therapy plays a central role in treating advanced and metastatic GI NETs. These innovative treatments are designed to interfere with the specific biological processes that help cancer cells grow and survive.
Common targeted drugs for gastrointestinal carcinoid tumors include somatostatin analogs, which can help control hormone-related symptoms and slow tumor growth. Other medications may also be used depending on the behavior and molecular features of the tumor.
Potential risks and side effects of targeted therapy for gastrointestinal carcinoid tumors
Targeted therapy is generally better tolerated than traditional chemotherapy, but it can still cause side effects. During treatment, the patient may experience fatigue, diarrhea, abdominal discomfort, nausea or changes in blood sugar levels. Some patients also have injection-site reactions with somatostatin analogs or skin changes and mouth sores with certain oral targeted medications.
Less commonly, targeted therapy can affect liver function, blood cell counts or hormone levels. Because the side effects can vary based on the specific drug used and the patient’s overall health, the healthcare team will closely monitor the patient throughout targeted therapy and adjust the treatment plan as needed to manage any symptoms and maintain quality of life.
Florida's First NCI-designated Comprehensive Cancer Center
Recognized for its scientific excellence, Moffitt is the state's longest-established National Cancer Institute-designated Comprehensive Cancer Center.
Preparing for targeted therapy and what to expect
Before starting targeted therapy, the patient will undergo imaging studies, blood tests and a comprehensive medical evaluation to confirm the treatment is appropriate based on the tumor type and cancer stage. The healthcare team will explain how the therapy will be given, whether by injection or oral medication, and how often it will be scheduled.
During targeted therapy, most patients can continue their daily activities with minimal disruption. Regular follow-up visits will be necessary to monitor the response to treatment and any side effects. Through periodic blood work and imaging scans, the healthcare team can help ensure the therapy is effective and well-tolerated.
Chemotherapy for gastrointestinal carcinoid tumors
Chemotherapy is less frequently used for GI NETs than other treatments, mainly because these tumors often grow slowly and may not respond well to standard chemotherapy drugs. However, chemotherapy may be considered for a high-grade or aggressive neuroendocrine tumor, or if other treatments are ineffective.
Potential risks and side effects of chemotherapy for gastrointestinal carcinoid tumors
The side effects of chemotherapy can vary depending on the drugs used, the patient’s overall health and other factors. Common experiences include fatigue, nausea, hair loss, lowered blood cell counts and increased risk of infection. Many side effects are temporary and can be managed with supportive care.
Preparing for chemotherapy and recovery between cycles
Before starting chemotherapy, the patient will meet with the healthcare team to review the treatment plan and potential side effects. Chemotherapy is typically given in cycles with breaks scheduled between active sessions to allow the body time to recover. During treatment, the patient will be closely monitored to manage any side effects and adjust the care plan if needed.
Radiation therapy for gastrointestinal carcinoid tumors
Although radiation therapy is not commonly used as a primary treatment for GI NETs, it may be considered in certain clinical scenarios. Radiation therapy uses high-energy beams to destroy cancer cells or slow their growth. For instance, it may be used to relieve symptoms caused by a gastrointestinal carcinoid tumor that cannot be surgically removed or treat a specific area of metastatic cancer.
Potential risks and side effects of radiation therapy for gastrointestinal carcinoid tumors
The side effects of radiation therapy can vary depending on the area of the body treated. Common experiences include skin irritation, fatigue, nausea and changes in bowel habits. Most side effects gradually improve after treatment ends.
Preparing for radiation therapy and what to expect
The patient will receive an individualized radiation therapy plan designed to precisely target the cancer cells while sparing the surrounding healthy tissues. Typically, the treatment is delivered over several sessions, and the healthcare team will be available to provide ongoing support throughout the process.
Clinical trials for gastrointestinal carcinoid tumors
Clinical trials are important research studies that offer certain patients unique opportunities to explore promising new treatment strategies for GI NETs before those options are made widely available. Eligibility can vary depending on several factors, including the type and stage of the tumor and the patient’s overall health and prior treatments.
Frequently asked questions (FAQs) about gastrointestinal carcinoid tumor treatment
Patients often have questions about what to expect before, during and after treatment for GI NETs. The information below addresses some common concerns and offers practical guidance, which can help a patient feel more informed and prepared as they move forward with care.
Benefit from world-class care at Moffitt Cancer Center
Moffitt is nationally recognized for its leadership in treating rare and complex cancers, including gastrointestinal carcinoid tumors. Our patients benefit from multispecialty expertise, advanced diagnostic tools and access to leading-edge research, all focused on delivering individualized cancer care.
If you would like to learn more about gastrointestinal carcinoid tumor treatment, you can request an appointment with a specialist in Moffitt’s renowned Gastrointestinal Oncology Program by calling 1-888-663-3488 or submitting a new patient registration form online. We do not require referrals.
Treatment